GRAMINEX®, L.L.C. Final Publication of a Peer Reviewed Clinical Trial with Graminex® Flower Pollen Extract Focusing on Women’s Urinary Incontinence in Current Urology.
May 13 2024 - 5:00AM
Business Wire
Graminex®, L.L.C. is pleased to announce publication of a peer
reviewed clinical study with Graminex® Flower Pollen Extract for
women’s urinary incontinence and urinary health in Current Urology.
The study was conducted as a randomized, double-blind,
placebo-controlled study to investigate the effectiveness of
Graminex® Flower Pollen Extracts in 114 healthy women with urinary
incontinence. It was concluded that significant and meaningful
reductions in UI severity were found in the Graminex® RCT Fem™ UI
study group along with significant improvement in stress-induced
urinary leakage volume with the PollenBerry® study group. A full
version is available at: Current Urology - Original Article
“Many women experience urinary incontinence throughout their
lives during postpartum, menopause, and the natural aging process.
There is limited natural support to help improve the symptoms of
urinary incontinence currently on the market. With this peer
reviewed publication, Graminex is excited to offer a natural
product to help improve women’s lives, when it’s needed most,” said
Colleen May, CBO.
About Graminex®, L.L.C.
Graminex®,L.L.C. is the leading producer of natural and
non-solvent Graminex® Flower Pollen Extract™. Graminex® directly
owns and manages more than 6,500 acres of farmland in Northwest
Ohio to meet its customer’s needs. Graminex’s active ingredients
are grown and processed for the dietary supplement, nutraceutical,
pharmaceutical, food and skin care industries. Graminex® markets
its own branded line of raw materials and dietary supplements,
focusing on prostate care, urinary care, menopausal support, and
skin care.
For further information please contact Graminex®,L.L.C., Colleen
May at +1 (419) 278-1023 or by e-mail at graminex@graminex.com. You
may also visit www.graminex.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240513362788/en/
Colleen E. May Chief Business Officer bugs@graminex.com +1 (419)
278-1023